Overview: Aspartate Aminotransferase TestIntroduction: The Aspartate Aminotransferase Test measures AST to diagnose liver or heart damage, causing jaundice or chest pain. Aligned with 2023 AASLD guidelines, it uses biochemical methods for high specificity, supporting liver screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in biochemistry for patients with suspected liver or cardiac disorders.
Other Names: SGOT Assay, AST Test.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic accuracy.
Historical Milestone: AST testing began in the 1950s with liver enzyme research. Biochemical methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Measures AST to diagnose liver or heart damage, guides treatment, and evaluates patients with jaundice or chest pain.
Test Parameters: 1. AST Level
Pretest Condition: Fasting for 10-12 hours required. Collect serum or plasma. Report history of jaundice, chest pain, or liver/cardiac symptoms.
Specimen: Serum (SST, 2-5 mL), Plasma (EDTA, 2-4 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document jaundice, chest pain, or history of liver/heart disorders. Include current medications, especially hepatotoxic drugs.
Consent: Written consent required, detailing the tests purpose, liver/heart damage implications, and risks of sample collection.
Procedural Considerations: Uses enzymatic assays to measure AST levels. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for liver or heart damage diagnosis.
Factors Affecting Result Accuracy: Improper fasting or sample hemolysis can affect results. Alcohol consumption or medications may elevate AST levels.
Clinical Significance: Elevated AST confirms liver or heart damage, guiding hepatoprotective or cardiac therapies. Normal levels may require ALT or cardiac marker testing.
Specialist Consultation: Consult a hepatologist or cardiologist for result interpretation and treatment planning.
Additional Supporting Tests: ALT, GGT, troponin, or liver imaging to confirm liver/heart damage diagnosis.
Test Limitations: Non-specific for liver vs. heart damage; clinical correlation is needed. Sample quality affects sensitivity.
References: AASLD Liver Guidelines, 2023; Clinical Chemistry, Kwo PY, 2022.
